These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
27. Mesalazine induced exacerbation of ulcerative colitis. Kapur KC; Williams GT; Allison MC Gut; 1995 Dec; 37(6):838-9. PubMed ID: 8537058 [TBL] [Abstract][Full Text] [Related]
28. Mesalazine (5-aminosalicylic acid) suppositories in the treatment of ulcerative proctitis or distal proctosigmoiditis. A randomized controlled trial. Campieri M; De Franchis R; Bianchi Porro G; Ranzi T; Brunetti G; Barbara L Scand J Gastroenterol; 1990 Jul; 25(7):663-8. PubMed ID: 2204103 [TBL] [Abstract][Full Text] [Related]
31. [Nephritis from 5-aminosalicylic acid]. von Mühlendahl KE Dtsch Med Wochenschr; 1989 Feb; 114(6):236. PubMed ID: 2917484 [No Abstract] [Full Text] [Related]
32. Lung and skin hypersensitivity to 5-aminosalicylic acid. le Gros V; Saveuse H; Lesur G; Brion N BMJ; 1991 Apr; 302(6782):970. PubMed ID: 1827746 [No Abstract] [Full Text] [Related]
33. Use of mesalamine and olsalazine in ulcerative colitis. Gait JE; Powell JH; Regalli G Am Fam Physician; 1993 Nov; 48(7):1234, 1236. PubMed ID: 8237737 [No Abstract] [Full Text] [Related]
34. Effect of sulphapyridine, 5-aminosalicylic acid, and placebo in patients with idiopathic proctitis: a study to determine the active therapeutic moiety of sulphasalazine. van Hees PA; Bakker JH; van Tongeren JH Gut; 1980 Jul; 21(7):632-5. PubMed ID: 6107263 [TBL] [Abstract][Full Text] [Related]
35. Pancreatitis induced by mesalamine. Erdkamp F; Houben M; Ackerman E; Breed W; van Spreeuwel J Neth J Med; 1992 Aug; 41(1-2):71-3. PubMed ID: 1407243 [TBL] [Abstract][Full Text] [Related]
36. Comparative pharmacokinetics of equimolar doses of 5-aminosalicylate administered as oral mesalamine (Asacol) and balsalazide: a randomized, single-dose, crossover study in healthy volunteers. Sandborn WJ; Hanauer SB; Buch A Aliment Pharmacol Ther; 2004 May; 19(10):1089-98. PubMed ID: 15142198 [TBL] [Abstract][Full Text] [Related]
37. Uncoated versus coated 5-aminosalicylic acid in Crohn's disease. Bossi A; Giuliani GE; Del Poggio P; Fenili D; Ragaini S Lancet; 1989 Feb; 1(8632):276. PubMed ID: 2563434 [No Abstract] [Full Text] [Related]
38. Risk of diarrhea related to iron content of infant formula: lack of evidence to support the use of low-iron formula as a supplement for breastfed infants. Scariati PD; Grummer-Strawn LM; Fein SB; Yip R Pediatrics; 1997 Mar; 99(3):E2. PubMed ID: 9099767 [TBL] [Abstract][Full Text] [Related]
40. Delayed onset of weanling diarrhoea associated with high breast milk intake. Watkinson M Trans R Soc Trop Med Hyg; 1981; 75(3):432-5. PubMed ID: 7324111 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]